Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Henagliflozin on the Remission of Prediabetes Population: A National Multicenter, Randomized Controlled Study

NCT06448130 is registered in ClinicalTrials.gov with Shandong Provincial Hospital as lead sponsor.

NCT NCT06448130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06448130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Henagliflozin on the Remission of Prediabetes Population: A National Multicenter, Randomized Controlled Study
Lead sponsor
Shandong Provincial Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
June 30, 2024
Completion date
December 31, 2027
Enrollment
984 (estimated)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

glucose metabolism disorders, prediabetes, prediabetic state, type 2 diabetes